Welcome Address – Coronary / Structural Symposium


Dear Colleague,

We would like to welcome you to the 20th annual Live Symposium of Complex Coronary,Valvular and Vascular Cases

The field of Interventional Cardiology, along with Structural Heart Disease intervention and Endovascular interventions, continues to evolve with the rapid growth of established and new technology supplemented constantly by the results of the latest randomized trials and registries, with the common goal of improving procedural efficiency and safety. As practicing Interventionalists, we must constantly make changes to appropriately treat coronary, valvular, and peripheral vascular disease based on the available devices, therapy and trial results. Hence, we need to participate in continuing educational activities to remain current. The issue of appropriateness, and cost-effectiveness of a new techniques or technology always needs to be weighed against the established practices, before making any decision in our daily practice.

That is exactly what we plan to achieve in our three-day Complex Coronary, Valvular and Vascular Cases Symposium; to present concise and current important information that will update you on the latest techniques and technologies and help clarify emerging areas of diagnostic and therapeutic controversy. To cover all the emerging areas in the field of intervention, we have dedicated separate days to topics of Endovascular Intervention on June 14th and Coronary Intervention and Structural heart disease intervention on June 15th. We plan to present the interventional format consistent with the guidelines for appropriateness of coronary revascularization. We will continue to offer recent updates of the Cath Lab along with various operational and technical topics in the dedicated one-day Nurse Technologist Symposium on June 16th.

The primary focus of this course is to present a multi-device approach to complex revascularization of patients with complex coronary, structural heart and endovascular disease. Various novel interventional devices such as transcatheter aortic-valve replacement (TAVR) and newer techniques such as retrograde CTO recanalization and dedicated bifurcation stenting will be demonstrated using live case presentations as platform for discussion by the operators, panelists and audience. The program is complemented by unbiased commentary of live cases by world renowned experts and discussions intended to bring out general consensus regarding the most effective appropriate strategy that you can apply immediately in your practice.

In addition, the course will present updates on the common topics of controversy we frequently encounter in the field of interventional cardiovascular medicine. There will be selected lectures on various topics of interventional cardiology. These updates will supplement the live cases with an up-to-date, comprehensive review of the most important and controversial topics of the current year.

We are committed to offer the 2017 Live Symposium as a platform for continued innovation in interventional cardiovascular medicine with the main interest of achieving safe procedural outcomes and strong emphasis on the appropriateness of the revascularization choice.

We look forward to seeing you at this year’s symposium!Sincerely, Coronary / Structural Heart Symposium Directors

Samin K. Sharma, MD, FACC, FSCAI

Director, Clinical and Interventional Cardiology
President, Mount Sinai Heart Network
Dean of International Clinical Affiliations
Zena and Michael A. Wiener Professor of Medicine
The Mount Sinai Hospital, New York, New York


Annapoorna S. Kini, MD, MRCP, FACC

Director, Cardiac Catheterization Laboratory
Director, Interventional Cardiology Fellowship Program
Professor of Medicine, Cardiology
The Mount Sinai Hospital, New York, New York

Roxana Mehran


Director, Interventional Cardiovascular Research and Clinical Trials
Professor of Medicine (Evidence and Health Policy)
The Mount Sinai Hospital
New York, New York